Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barilli

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Metabolism: Clinical and Experimental|August 23, 2000
Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjectsI Zavaroni, P M Platti, L D Monti, et al.
Natural Product Research|June 7, 2006
Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaineD Passarella, A Barilli, S M N Efange, et al.
British Journal of Cancer|July 30, 2014
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenograftsM Chiu, S Tardito, S Pillozzi, et al.
Bioorganic & Medicinal Chemistry|November 19, 2022
The discovery of (1R, 3R)-1-(3-chloro-5-fluorophenyl)-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonitrile, a potent and selective agonist of human transient receptor potential cation channel subfamily m member 5 (TRPM5) and evaluation of as a potential gastrointestinal prokinetic agentM Sabat, L F Raveglia, L Aldegheri, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Metabolism: Clinical and Experimental|August 23, 2000
Plasma nitric oxide concentrations are elevated in insulin-resistant healthy subjectsI Zavaroni, P M Platti, L D Monti, et al.
Natural Product Research|June 7, 2006
Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaineD Passarella, A Barilli, S M N Efange, et al.
British Journal of Cancer|July 30, 2014
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenograftsM Chiu, S Tardito, S Pillozzi, et al.
Bioorganic & Medicinal Chemistry|November 19, 2022
The discovery of (1R, 3R)-1-(3-chloro-5-fluorophenyl)-3-(hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-6-carbonitrile, a potent and selective agonist of human transient receptor potential cation channel subfamily m member 5 (TRPM5) and evaluation of as a potential gastrointestinal prokinetic agentM Sabat, L F Raveglia, L Aldegheri, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
Pageof 3